GRANT HINDSLEY

Grant Hindsley is a photographer and journalist at The Buffalo News. His work focuses on HIV treatments and related health issues. He has covered the development of new regimens, including once-weekly pills and semiannual shots, which could help control the virus in hard-to-reach populations. Hindsley's photographs and articles provide valuable insights into the ongoing research and efforts to combat HIV/AIDS. His reporting is characterized by a strong commitment to accuracy and fairness, as well as an ability to convey complex medical information in an accessible manner.

Biography:  https://buffalonews.com/hiv-treatments-1/image_e1970805-ea12-58d3-97a8-73381e2d4268.html

98%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Revolutionizing HIV Treatment: The Promise of Long-Acting Drugs

Revolutionizing HIV Treatment: The Promise of Long-Acting Drugs

Broke On: Monday, 11 March 2024 Scientists are developing long-acting HIV drugs, including once-weekly pills and semiannual shots, which could ease stigma and improve adherence to treatment plans. Companies like Gsk Plc, Merck & Co., Unitaid, and Viiv Healthcare Ltd. aim to make HIV management easier with these innovations.
Revolutionizing HIV Treatment: The Promise of Long-Acting Drugs

Revolutionizing HIV Treatment: The Promise of Long-Acting Drugs

Broke On: Monday, 11 March 2024 Scientists are developing long-acting HIV drugs, including once-weekly pills and semiannual shots, which could ease stigma and improve adherence to treatment plans. Companies like Gsk Plc, Merck & Co., Unitaid, and Viiv Healthcare Ltd. aim to make HIV management easier with these innovations.